Re: SUCCINCT: An Open-Label, Single-Arm, Non-Randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-Line Treatment for Patients with Advanced Urothelial Carcinoma

J Urol. 2015 Dec;194(6):1583-4. doi: 10.1016/j.juro.2015.09.005. Epub 2015 Sep 5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / toxicity*
  • Bone Marrow Diseases / chemically induced*
  • Cisplatin / therapeutic use*
  • Deoxycytidine / analogs & derivatives*
  • Female
  • Humans
  • Indoles / toxicity*
  • Male
  • Pyrroles / toxicity*
  • Urologic Neoplasms / drug therapy*

Substances

  • Indoles
  • Pyrroles
  • Deoxycytidine
  • Cisplatin